Phreesia (NYSE:PHR) Stock Price Up 5.6% - Here's What Happened

Key Points

• Shares of Phreesia rose 5.6% to about $8.84 on Monday, with 772,144 shares traded — roughly a 60% decline from average session volume.
• Phreesia reported Q1 EPS of $0.02, missing the consensus of $0.07, while revenue grew 15.9% year‑over‑year to $127.07 million.
• Analyst views are mixed: MarketBeat shows an average rating of Moderate Buy and an average price target of $22, but several major firms have recently cut targets sharply (e.g., Citigroup to $10, Truist to $11, Needham to $14).

Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) traded up 5.6% on Monday . The company traded as high as $8.88 and last traded at $8.8370. 772,144 shares were traded during trading, a decline of 60% from the average session volume of 1,929,251 shares. The stock had previously closed at $8.37.

Wall Street Analysts Forecast Growth

PHR has been the subject of a number of research analyst reports. Wall Street Zen cut shares of Phreesia from a "buy" rating to a "hold" rating in a research report on Saturday. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Phreesia in a report on Wednesday, January 28th. Citigroup restated a "neutral" rating and set a $10.00 price objective (down from $25.00) on shares of Phreesia in a research report on Tuesday, March 31st. Truist Financial reaffirmed a "hold" rating and issued a $11.00 target price (down from $24.00) on shares of Phreesia in a research report on Tuesday, March 31st. Finally, Needham & Company LLC reduced their price target on Phreesia from $35.00 to $14.00 and set a "buy" rating for the company in a research note on Tuesday, March 31st. Twelve research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Phreesia currently has an average rating of "Moderate Buy" and an average price target of $22.00.

Phreesia Stock Up 6.0%

The stock has a 50-day moving average of $11.92 and a 200-day moving average of $17.25. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.53 and a quick ratio of 2.44. The firm has a market cap of $538.94 million, a price-to-earnings ratio of 295.00 and a beta of 0.86.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Monday, March 30th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.05). The company had revenue of $127.07 million for the quarter, compared to analyst estimates of $126.75 million. Phreesia had a return on equity of 3.23% and a net margin of 0.48%.The business's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period last year, the company posted ($0.11) earnings per share. Sell-side analysts predict that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Insider Activity

In other news, insider Evan Roberts sold 6,317 shares of the company's stock in a transaction that occurred on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $107,452.17. Following the completion of the sale, the insider owned 834,632 shares of the company's stock, valued at approximately $14,197,090.32. This represents a 0.75% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider David Linetsky sold 6,106 shares of Phreesia stock in a transaction that occurred on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $103,863.06. Following the completion of the transaction, the insider directly owned 231,723 shares in the company, valued at $3,941,608.23. This trade represents a 2.57% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 70,358 shares of company stock valued at $1,123,569 over the last quarter. 5.50% of the stock is owned by corporate insiders.

Institutional Trading of Phreesia

Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. grew its position in Phreesia by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 5,744,326 shares of the company's stock valued at $97,194,000 after acquiring an additional 39,540 shares during the last quarter. Greenhouse Funds LLLP boosted its stake in shares of Phreesia by 16.8% in the 3rd quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company's stock valued at $91,317,000 after purchasing an additional 557,265 shares in the last quarter. Granahan Investment Management LLC grew its holdings in shares of Phreesia by 73.8% during the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company's stock valued at $40,601,000 after purchasing an additional 1,018,987 shares during the last quarter. Franklin Resources Inc. increased its position in Phreesia by 28.8% during the 4th quarter. Franklin Resources Inc. now owns 2,000,082 shares of the company's stock worth $33,841,000 after purchasing an additional 446,890 shares in the last quarter. Finally, Nuveen LLC lifted its stake in Phreesia by 12.7% in the 4th quarter. Nuveen LLC now owns 1,875,725 shares of the company's stock valued at $31,737,000 after purchasing an additional 211,262 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.